Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-019-01561-1
Abstract: BackgroundEfficacy of 8-week regimen with direct-acting antivirals (DAA) for patients with hepatitis C after liver transplantation has not been clarified. This study aimed to clarify the efficacy and safety of glecaprevir and pibrentasvir therapy for… read more here.
Keywords: hepatitis liver; treatment; liver; liver transplantation ... See more keywords
Liver safety assessment in clinical trials of new agents for chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13223
Abstract: Investigational agents that reduce or eliminate covalently closed circular DNA (cccDNA) or enhance host immunity against hepatitis B virus (HBV)‐infected hepatocytes are intended to induce a durable off‐treatment clearance of hepatitis B surface antigen (HBsAg)… read more here.
Keywords: liver safety; clinical trials; safety; hepatitis liver ... See more keywords
Management of chronic hepatitis B before and after liver transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Frontline Gastroenterology"
DOI: 10.1136/flgastro-2016-100768
Abstract: Chronic hepatitis B infection is a global public health problem associated with significant morbidity and mortality. Persistent infection may evolve to liver cirrhosis and hepatocellular carcinoma, and hepatitis B-related liver disease is a common indication… read more here.
Keywords: hepatitis; management; liver transplantation; chronic hepatitis ... See more keywords
Risk factors for postoperative portal vein thrombosis in patients with hepatitis B liver cancer and its impact on mortality—a retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "Translational Cancer Research"
DOI: 10.21037/tcr-22-1837
Abstract: Background The treatment of portal thrombosis is very difficult, which can seriously affect the prognosis of the patients, and thus, preventing postoperative portal thrombosis in patients with hepatitis B liver cancer is crucial. Identifying the… read more here.
Keywords: liver cancer; patients hepatitis; hepatitis liver; portal vein ... See more keywords